—
Over the past few years, medical foods have emerged as a tool for physicians to manage many gastrointestinal disorders, such as IBS, IBD, and HIV-associated enteropathy, as well as nongastrointestinal disorders. This paper discusses how multiple animal and human studies have provided the data purporting to show the efficacy of medical foods.Safe medical foods may be the initial step in managing various gastrointestinal disorders before moving to drugs with known and higher side-effect profiles. In addition, because the medical foods reviewed in this article do not have major food or drug interactions, they may be considered as add-on therapies in patients with more serious gastrointestinal conditions, as they can work alongside drugs in disease management to improve patient outcomes. More research will be needed to continue to evaluate medical food potential on patient care.
Featured products:
– EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI), which has been studied extensively in diarrhea-predominant irritable bowel syndrome, inflammatory bowel disease (IBD), and HIV-associated enteropathy.
– VSL#3, a probiotic that is used in pouchitis for patients with ulcerative colitis as well as irritable bowel syndrome.
– Modulen IBD, a whole-protein, sole-nutrition formulation used to manage the active phase of Crohn’s disease.
– Vivonex is an elemental diet that is used in a variety of diseases associated with severe gastrointestinal dysfunction.
Read the paper.
“It’s important for the category of medical foods to get more attention within the healthcare industry,” said Aage Lauridsen, Chief Executive Officer of Entera Health Inc. “Our product EnteraGam® is helping patients every day with managing chronic diarrhea and loose stools. The more healthcare professionals and patients who know about it and these other medical foods, the greater the opportunity for even more safe, therapeutic care.”
Learn about EnteraGam®.
About EnteraGam® / Intended Use:
EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI) is a medical food product intended for the dietary management of chronic diarrhea and loose stools. EnteraGam® must be administered under medical supervision.
Important Safety Information:
EnteraGam® contains beef protein: therefore, patients who have an allergy to beef or any other component of EnteraGam® should not take this product. EnteraGam® has not been studied in pregnant women, in women during labor and delivery, or in nursing mothers. The choice to administer EnteraGam® during pregnancy, labor and delivery, or to nursing mothers is at the clinical discretion of the prescribing physician.
EnteraGam® does not contain any milk-derived ingredients such as lactose, casein, or whey. EnteraGam® is gluten-free, dye-free, and soy-free.
Please see full Product Information.
To report suspected adverse reactions, contact Entera Health, Inc. at 1-855-4ENTERA (1-855-436-8372), or the FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch.
CITATION: 1. Ciampa B, Ramos ER, Borum M, Doman DB. The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders. Gastroenterology & Hepatology. 2017;13(2):104-115.
Contact Info:
Name: Aage Lauridsen
Email: Send Email
Organization: Entera Health Inc.
Address: 2000 Regency Pkwy, Cary, NC 27518
Phone: 515-963-7599
Website: http://enterahealth.com
Release ID: 173152
Google
RSS